4,098 reports of this reaction
7.9% of all VORICONAZOLE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for VORICONAZOLE, manufactured by Roerig. There are 4,098 FDA adverse event reports linking VORICONAZOLE to DRUG INEFFECTIVE. This represents approximately 7.9% of all 52,026 adverse event reports for this drug.
VORICONAZOLE has an overall safety score of 88 out of 100. Patients taking VORICONAZOLE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among VORICONAZOLE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for VORICONAZOLE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 4,098 FDA reports for VORICONAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 7.9% of all adverse event reports for VORICONAZOLE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking VORICONAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.